{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:42:17Z","timestamp":1776336137350,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Research Foundation DFG"},{"DOI":"10.13039\/100005156","name":"Humboldt Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neuropharm.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T13:16:45Z","timestamp":1347974205000},"page":"83-89","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: The role of serotonin and different forebrain neuronal subpopulations"],"prefix":"10.1016","volume":"65","author":[{"given":"M.","family":"H\u00e4ring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Monory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.09.002_bib1","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behaviour and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib2","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/npp.2010.80","article-title":"Genetic deletion of fatty acid amide hydrolase alters emotional behaviour and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus","volume":"35","author":"Bambico","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pnpbp.2012.02.006","article-title":"Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission","volume":"38","author":"Bambico","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by \u03949-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2010.03.020","article-title":"Depression-like phenotype following chronic CB1 receptor antagonism","volume":"39","author":"Beyer","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of \u03949-tetrahydrocannabinol and AM404, the anandamide transport inhibitor, in Sprague-Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib7","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.21-24-09917.2001","article-title":"Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABAA, and glutamate receptors","volume":"21","author":"Celada","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00455973","article-title":"Central effects of an inhibitor of tyrosine hydroxylation","volume":"10","author":"Corrodi","year":"1966","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","article-title":"In search of a depressed mouse: utility of models for studying depression-related behaviour in genetically modified mice","volume":"9","author":"Cryan","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2008.03.046","article-title":"\u03949-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB1 receptor and serotonergic system","volume":"589","author":"Egashira","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of \u03949-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib12","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.pnpbp.2010.11.021","article-title":"Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants","volume":"35","author":"Gorzalka","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","article-title":"Adverse effects of cannabis","volume":"352","author":"Hall","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2007.02.021","article-title":"Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice","volume":"146","author":"H\u00e4ring","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib17","doi-asserted-by":"crossref","first-page":"e26617","DOI":"10.1371\/journal.pone.0026617","article-title":"Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration","volume":"6","author":"H\u00e4ring","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2011.12.035","article-title":"Neuronal populations mediating the effects of endocannabinoids on stress and emotionality","volume":"204","author":"H\u00e4ring","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1586\/14737175.8.4.537","article-title":"Escitalopram for the treatment of major depression and anxiety disorders","volume":"8","author":"H\u00f6schl","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1601-183X.2009.00512.x","article-title":"Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission","volume":"8","author":"Jacob","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cne.10976","article-title":"Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons","volume":"468","author":"Jankowski","year":"2004","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pbb.2010.02.011","article-title":"Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice","volume":"95","author":"Jesse","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib24","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic and antidepressant-like effects","volume":"115","author":"Jiang","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2005.05.025","article-title":"Involvement of 5-HT1A receptors in the antidepressant-like effects of adenosine in the forced swim test","volume":"67","author":"Kaster","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2009.07.014","article-title":"Bidirectional regulation of novelty-induced behavioural inhibition by the endocannabinoid system","volume":"57","author":"Lafen\u00eatre","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/endo.141.4.7407","article-title":"Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus","volume":"141","author":"Laorden","year":"2000","journal-title":"Endocrinologist"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib29","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/en.2011-1220","article-title":"CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice","volume":"152","author":"Lockie","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib31","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1523\/JNEUROSCI.2648-09.2010","article-title":"Alterations in the hippocampal endocannabinoid system in diet-induced obese mice","volume":"30","author":"Massa","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","article-title":"The psychiatric side effects of rimonabant","volume":"31","author":"Moreira","year":"2009","journal-title":"Rev. Bras. Psiquiatr"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1369-1600.2008.00104.x","article-title":"The endocannabinoid system: emotion, learning and addiction","volume":"13","author":"Moreira","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side effects of therapies based on CB1 cannabinoid receptors agonist and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib36","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1460-9568.2006.04759.x","article-title":"Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons","volume":"23","author":"Muntoni","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-007-0728-9","article-title":"Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test","volume":"192","author":"O'Leary","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2007.09.008","article-title":"Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice","volume":"33","author":"Steiner","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.tpj.6500466","article-title":"Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behaviour in mice","volume":"8","author":"Steiner","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib43","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.psyneuen.2008.06.004","article-title":"Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses","volume":"33","author":"Steiner","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2012.09.002_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib46","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0024-3205(65)90223-7","article-title":"Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase","volume":"4","author":"Weissman","year":"1965","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1389557054368763","article-title":"Role of endogenous cannabinoids in cognition and emotionality","volume":"5","author":"Wotjak","year":"2005","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible role of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.002_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by \u03949-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T22:00:09Z","timestamp":1562191209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812004741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":49,"alternative-id":["S0028390812004741"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.09.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}